Early Recognition of Relapse and Refractory Response to Myeloma Treatment
Learn from Dr. Amandeep Godara, a multiple myeloma and amyloidosis specialist based at Huntsman, as he shares with us how to detect relapse or refractory signs early on. What does a relapse really look like? What are the signs of relapse? What does being refractory look like and how soon can it show up on tests? Help us raise awareness for myeloma patients and communities so better treatment decisions can be made quicker. Come with your questions!
Nico Cheek-O'Donnell
Nico joined the Multiple Myeloma Program at Huntsman Cancer Institute in 2016, as its licensed clinical social worker. Before that, he was a social worker with Intermountain, primarily at LDS Hospital on their inpatient behavioral unit. He earned his Master of Social Work degree at the University of Utah. Originally from New York & Boston, Nico earned undergraduate degrees in Psychology & Theatre from Carleton College in Minnesota. He earned most of his very modest living as a stage actor in Minneapolis and Seattle for eight years, before moving to Utah in 2006. More recently, Nico has used role-play to help train physicians how to navigate especially difficult patient conversations – and to entertain his 13 & 9-year-old kids.
Amandeep Godara, MBBS
Dr. Amandeep Godara completed his hematology-oncology fellowship at Tufts Medical Center with a clinical and research interest in plasma cell disorders. His research focuses on developing new therapeutic targets and tools for assessment of treatment response in multiple myeloma, amyloidosis and other monoclonal gammopathies. His work has been presented at national and international scientific meetings. He was the recipient of Amyloidosis Foundation David Seldin, MD, PhD Memorial Research Grant in 2019. He also received training in blood and marrow transplantation at Stanford University. He completed his medical school at Government Medical College, Aurangabad, India, and his internal medicine residency at Wayne State University. Dr. Godara treats patients with Multiple Myeloma, Amyloidosis, Waldenstrom’s Macroglobulinemia, and other plasma cell disorders.